A new genetic test, that could be on the market within a few years, aims to accurately determine a man’s likelihood of developing prostate cancer.
Swedish scientists have determined the role that certain inherited genetic markers play in making some men more susceptible to the disease. Currently five genes are known to play a role in prostate cancer, however each of these genes by itself has only a small impact on the probability of a person developing prostate cancer.
Now however, the researchers have determined the cumulative effect of these genes and found that a person carrying four of more of these genes can be up to five times more likely to develop prostate cancer than a person with few or none of the genes.
According to Professor Henrik Gronberg of the Karolinska Institute in Sweden – “For the first time, this type of study has made it possible to develop a clinically viable gene test,”.
The study will be published in the January 31 issue of the New England Journal of Medicine.
A genetic test for prostate cancer could be publicly available in just a few months and is expected to carry a price tag of less than $300.
According to leading medical experts, this could be the first in a new wave of genetic tests over the next few decades that can determine a persons susceptibility to a wide variety of cancers and other illnesses.
Similar Articles You Might Like:
- Broccoli Rich Diets Ward Off Prostate Cancer
- Regular Exercise May Cut Cancer Risk In Men
- High Dose Vitamin E May Actually Increase Risk Of Prostate Cancer
- Dairy Products Linked To Increased Risk Of Prostate Cancer
- Abdominal Fat May Be Linked To Pancreatic Cancer
- Non-Hodgkin Lymphoma Sufferers Are Living Longer
- Obesity Linked To Cancer Of Pancreas, Liver, Bladder & Prostate
- What Are A Smokers Chances Of Dying From Lung Cancer?